Opioid-induced constipation can be a frustrating and debilitating side effect of pain management. Fortunately, medical professionals now have access to naloxegol, a medication that specifically targets this issue. In this comprehensive guide, we'll unpack everything you need to know about naloxegol, including its pros and cons, potential side effects, and cost. By the end of this article, you'll have a thorough understanding of how naloxegol works and whether it's the right treatment option for your patients with opioid-induced constipation. So let's dive in!
Naloxegol, also known as Movantik, is a medication used to treat opioid-induced constipation. While it has been proven effective in relieving constipation symptoms caused by opioids, like any other medication, it has its pros and cons.
One of the main advantages of Naloxegol is that it works by blocking the opioid receptors in the gut without affecting pain relief. This means that patients can continue taking their prescribed opioids while also managing their constipation symptoms.
Another advantage is that Naloxegol has a lower risk of abuse than other medications for constipation relief because it does not produce a high or euphoric effect.
On the downside, some common side effects of Naloxegol include abdominal pain, diarrhea, nausea, vomiting and headaches. In rare cases, patients may experience severe allergic reactions which require immediate medical attention.
Another disadvantage is that Naloxegol should be used with caution in patients with liver problems or those taking medications metabolized by CYP3A4 enzymes because it may increase drug levels in the blood leading to potential adverse drug interactions.
Naloxegol is an effective medication for treating opioid-induced constipation, but like any other drug, it comes with potential side effects. While most patients tolerate naloxegol well, some may experience adverse reactions.
One of the most common side effects of Naloxegol is nausea. Patients may feel queasy and uncomfortable after taking the medication. Other gastrointestinal symptoms like diarrhea, vomiting and abdominal pain have also been reported in some cases.
In rare instances, naloxegol can lead to severe allergic reactions such as hives or swelling of the face. In case this happens to a patient, immediate medical attention should be sought.
Some people may also experience headaches while using naloxegol. Dizziness and fatigue are other possible side effects that could affect daily activities.
Naloxegol is a promising medication for managing opioid-induced constipation in patients who are not responding well to other laxatives. It has been shown to be effective and generally safe with few side effects.
As medical professionals, it is important to understand the pros and cons of using naloxegol as part of our treatment strategies. We must monitor our patients closely for any potential side effects and educate them on how to properly use the medication.
Naloxegol offers another option for managing opioid-induced constipation and can greatly improve the quality of life for those suffering from this condition.
1.
Radioactive ion beams successfully treat animal tumors in study
2.
A computer-aided diagnostic system for improved detection of breast cancer.
3.
Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.
4.
Study reveals that older women frequently receive an incorrect breast cancer diagnosis.
5.
Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer
1.
The Impact of Microadenoma on Hormonal Health
2.
Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy
3.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
4.
The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition
5.
Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
2.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation